Hand numbness, neck-shoulder pain, and grip weakness that worsen when the arm is raised. PEMF is a non-invasive adjunct that supports the conservative pathway — reducing perineural edema and supporting microcirculation around the compressed brachial plexus.
July 2026 · 8 min read · Nerve Entrapment Protocol
Thoracic Outlet Syndrome (TOS) is a group of conditions in which the brachial plexus nerves and/or the subclavian vessels are compressed as they pass through the narrow corridor between the clavicle, the first rib, and the scalene muscles at the base of the neck. Over 90% of cases are the neurogenic type, in which the nerves themselves are compressed — producing numbness, radiating pain, and grip weakness in the arm and hand.
The pain and paresthesia are characteristically provoked by raising and abducting the arm — hanging laundry, driving, holding an overhead handrail, or sleeping with the arm above the head — because these positions narrow the outlet further and increase traction on the plexus. This positional trigger helps distinguish TOS from more distal nerve entrapments such as carpal or cubital tunnel syndrome.
In the Philippine clinical setting, the leading drivers of neurogenic TOS are:
| Cause | Mechanism | Philippine Relevance |
|---|---|---|
| Forward-head / rounded-shoulder posture | Sustained scalene and pectoralis minor tightening narrows the outlet | Very large BPO / call-center and desk workforce with prolonged seated screen posture |
| Repetitive overhead work | Chronic traction and compression of the plexus during elevated-arm tasks | Common in construction, manufacturing, cargo handling, and overhead athletics |
| Whiplash / neck trauma | Scalene scarring and muscle spasm after acceleration-deceleration injury | High volume of motorcycle and road-traffic neck injuries |
| Congenital cervical rib / fibrous band | An extra rib or band mechanically narrows the outlet | Present in a small percentage of the population; often silent until adulthood |
| Muscular hypertrophy | Enlarged scalene / subclavius muscles reduce the available space | Seen in weight-training and heavy-labor populations |
PEMF (Pulsed Electromagnetic Field) therapy delivers brief, low-intensity magnetic pulses that act at the cellular level. In a nerve-entrapment context, the therapeutic aim is threefold:
This mechanism is complementary to the conservative goal of reducing mechanical load: while physiotherapy releases the compressing structures, PEMF supports the metabolic environment of the nerve. PEMF is a supportive adjunct — not a replacement for diagnosis or active rehabilitation.
Honest framing first: there is no dedicated randomized controlled trial (RCT) of PEMF for thoracic outlet syndrome specifically. The scientific basis is extrapolated from general PEMF evidence in joint and soft-tissue pain, applied to the shared mechanism of perineural edema and impaired microcirculation.
Because neurogenic TOS is characterized by perineural edema and compromised microcirculation, PEMF offers a reasonable clinical rationale for edema reduction and tissue support — used alongside, not instead of, exercise-based rehabilitation.
Conservative management is the evidence-based cornerstone; PEMF integrates as a supportive layer. Recommended sequence in clinic:
| Parameter | PEMF (adjunct) | Physiotherapy & Exercise | Local Nerve/Steroid Block |
|---|---|---|---|
| Primary goal | Reduce pain and edema, support nerve blood flow | Reduce mechanical load, correct posture, mobilize the nerve | Rapid local reduction of inflammation/pain |
| Invasiveness | Completely non-invasive | Non-invasive | Invasive (injection) |
| Patient experience | Comfortable, painless, no side effects | Active effort; transient muscle soreness possible | Local discomfort and mild injection pain |
| Therapist hands-on time | 0 minutes (Hands-Free) — treats in parallel | Hands-on and guidance throughout the session | ~15 minutes (full physician presence) |
| FDA status | Yes — for pain and edema (510k); adjunct use in TOS | Not applicable (manual therapy) | Yes — pharmacological approval |
| Repeat use | Safe as a treatment series, no dose ceiling | Ongoing throughout rehabilitation | Limited (steroid dose ceiling) |
PEMF suits patients with mild-to-moderate neurogenic TOS seeking a non-invasive adjunct alongside physiotherapy and posture correction:
Absolute contraindications: pregnancy; cardiac pacemaker or implanted defibrillator (ICD) and active electronic implants; uncontrolled epilepsy; active malignancy in the treatment field. Suspected venous or arterial TOS (sudden swelling, discoloration, a cold hand) requires urgent vascular referral — these are not cases for independent conservative treatment.
Neurogenic TOS patients are a chronic, high-course-completing segment drawn from a very large desk-and-BPO workforce:
Raising and abducting the arm narrows the corridor at the base of the neck and increases traction on the brachial plexus and subclavian vessels. That is why overhead tasks — and sleeping with the arm above the head — provoke numbness and a “falling asleep” sensation in the fingers. It is a hallmark positional trigger of TOS.
No. There are no needles, drugs, or heat. The patient sits or lies comfortably while the coil is placed over the neck-shoulder region, with no sensation of discomfort during the session.
A PEMF session lasts about 30 minutes. Typical frequency is 1–2 times per week (up to 3 in acute cases, with a rest day between sessions), delivered as a series rather than a single visit.
No. Physiotherapy, posture correction, and nerve-gliding exercises are the evidence-based cornerstone; PEMF is a complementary adjunct used alongside them — not a replacement.
Seek prompt evaluation for progressive grip weakness or dropping objects, visible muscle wasting in the hand, or sudden swelling, discoloration, or coldness of the hand (possible venous/arterial TOS). These require medical — and sometimes surgical or vascular — assessment.
Request the full investor package — PEMF protocols, device costs, ROI models, and the Philippine nerve-entrapment market analysis.
Request Investment Brief →